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Rift Valley fever (RVF) is a zoonotic disease caused by Rift Valley fever virus (RVFV) found
in Africa and the Middle East. Outbreaks can cause extensive morbidity and mortality in
humans and livestock. Following the diagnosis of two acute human RVF cases in Kabale
district, Uganda, we conducted a serosurvey to estimate RVFV seroprevalence in humans
and livestock and to identify associated risk factors.
Methods
Humans and animals at abattoirs and villages in Kabale district were sampled. Persons
were interviewed about RVFV exposure risk factors. Human blood was tested for anti-RVFV
IgM and IgG, and animal blood for anti-RVFV IgG.
Principal findings
655 human and 1051 animal blood samples were collected. Anti-RVFV IgG was detected in
78 (12%) human samples; 3 human samples (0.5%) had detectable IgM only, and 7 (1%)
had both IgM and IgG. Of the 10 IgM-positive persons, 2 samples were positive for RVFV by
PCR, confirming recent infection. Odds of RVFV seropositivity were greater in participants
who were butchers (odds ratio [OR] 5.1; 95% confidence interval [95% CI]: 1.7–15.1) and
those who reported handling raw meat (OR 3.4; 95% CI 1.2–9.8). No persons under age 20
were RVFV seropositive. The overall animal seropositivity was 13%, with 27% of cattle, 7%
of goats, and 4% of sheep seropositive.
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In a multivariate logistic regression, cattle species (OR 9.1; 95% CI 4.1–20.5), adult age
(OR 3.0; 95% CI 1.6–5.6), and female sex (OR 2.1; 95%CI 1.0–4.3) were significantly asso-
ciated with animal seropositivity. Individual human seropositivity was significantly associ-
ated with animal seropositivity by subcounty after adjusting for sex, age, and occupation
(p < 0.05).
Conclusions
Although no RVF cases had been detected in Uganda from 1968 to March 2016, our study
suggests that RVFV has been circulating undetected in both humans and animals living in
and around Kabale district. RVFV seropositivity in humans was associated with occupation,
suggesting that the primary mode of RVFV transmission to humans in Kabale district could
be through contact with animal blood or body fluids.
Author summary
Viral hemorrhagic fevers are known to cause high morbidity and mortality and pose a
serious threat to human and animal populations in endemic countries. An outbreak of
Rift Valley fever was detected in Kabale district in March, 2016 and identified the first
human cases in Uganda since 1968. There was a need to perform a rapid assessment of the
burden of Rift valley fever in Kabale district, identify undetected acute cases, identify risk
factors associated with human disease, identify areas at high-risk or future infections, and
to determine if this was a newly emerging infection or an endemic disease. Our study
found the seroprevalence to be as high as 28% in humans and 36% in animals within
some subcounties of Kabale district. Human seropositivity correlated with animal sero-
positivity, suggesting that animal to human transmission may be the predominant mode
of virus spread. Our findings also suggest that this virus may have been endemic for many
years prior to these human cases being identified.
Introduction
Rift Valley fever virus (RVFV) is a single-stranded RNA virus in the order Bunyavirales,
and recently classified in the Phenuiviridae family [1] and the Phlebovirus genus. RVFV
causes disease in humans and animals [2], and is transmitted by mosquitoes to livestock
such as sheep, goats, and cattle [3]. Competent mosquito vectors include species from
the Aedes, Culex, Anopheles, Eretmapodites, Mansonia, and Coquillettidia genera [4, 5].
Humans can become infected with RVFV when they come into contact with blood or
body fluids of infected livestock while caring for sick animals, assisting with animal birth,
or slaughtering livestock; or through bites of infected mosquitoes. Occupations at the
greatest risk of RVFV infection include herdsmen and butchers [6–8]. Raw milk or meat
consumption are potential sources of RVFV, although transmission via these routes has
not been confirmed.
In livestock, RVFV infection can cause increased abortions and stillbirths, and high
mortality in neonates and juvenile animals. As a result, RVFV outbreaks can lead to signifi-
cant economic losses [3, 9]. In humans, infection can range from asymptomatic or a mild
flu-like illness to more severe disease that includes hepatitis, retinitis, or encephalitis [10].
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Approximately 1% of human cases develop hemorrhagic disease, and an estimated 1–2% of
cases are fatal. However, during an outbreak in Saudi Arabia, case fatality was as high as
14% [10].
There is no specific treatment for RVFV infection in humans or animals, but supportive
care may prevent complications and decrease mortality [2]. Currently, no RVFV vaccine is
approved for use in either humans or animals in North America or Europe [3]. Some inacti-
vated and live-attenuated vaccines have been developed and have been efficacious in animals
[11, 12]. Development of human RVFV vaccines has been challenging due to the safety of the
vaccine. An experimental human vaccine, TSI-GSD200, has shown some utility in laboratory
workers, but has not been used extensively in other settings [11]. To better understand the util-
ity of RVFV vaccines in a particular setting, the prevalence of disease in humans and animals
must first be understood.
Rift Valley fever (RVF) outbreaks were first reported in East Africa in the 1930s [13]. In
1997–1998, large RVF outbreaks in northeastern Kenya were associated with El Niño rains
and floods, resulting in many deaths in livestock and humans [14, 15]. Infection in humans
was highly associated with contact with livestock and animal body fluids. RVF outbreaks were
not reported again in East Africa until 2006–2007, when large numbers of humans and live-
stock were infected in Kenya, Somalia, Tanzania, and Sudan [16, 17]. Studies following these
outbreaks reported that being a herdsman and handling or consuming products from infected
animals were major risk factors for human infection. Additionally, outbreaks in East African
countries mainly occurred in areas with poor soil drainage and flat lowlands that are less than
500 m above sea level [18, 19]. Also, RVF outbreaks in humans and animals following flooding
have occurred in Sudan [20], Saudi Arabia [21], Yemen (2000–2001), South Africa, and Egypt
[22].
Uganda is an East African nation that shares borders with Kenya and Tanzania, and to date
no large RVF outbreaks have been reported since 1968, when 7 human cases occurred near
Entebbe [23]. However, a 2013 serological survey of goats in Ssembabule, Mpigi, Masaka, and
Mubende districts in Uganda showed a seroprevalence of 9.8%, suggesting RVFV circulation
[24].
The Uganda Virus Research Institute (UVRI) in Entebbe has been implementing labora-
tory-based surveillance for viral hemorrhagic fevers (VHF) in Uganda since 2010, which
includes testing for RVFV [25]. In March 2016, UVRI confirmed 2 acute human RVF cases in
Kabale district in the southwestern region of Uganda [26]. These were the first human RVF
cases identified in Uganda since 1968 [23]. Because not all human or animal RVF cases are
symptomatic, RVFV infections are often undetected. Thus, UVRI, the Ugandan Ministry of
Health (MoH), Ugandan Ministry of Agriculture Animal Industry and Fisheries (MAIF), and
the United States Centers for Disease Control and Prevention (CDC) collaborated on a study
to assess the seroprevalence of RVFV in humans and animals living in and around Kabale dis-
trict. The objectives of the study were to determine the sero-prevalence of RVFV in both
humans and animals in Kabale and surrounding districts, identify risk factors and high-risk
areas for RVFV, determine if RVF is emerging or endemic, and identify unrecognized RVF
cases that may be related to the 2016 outbreak.
Methods
Ethics statement
Ethical approval for this study was granted from review by the UVRI Research Ethics Commit-
tee (UVRI REC: GC/127/16/03/551). Animal subjects work was conducted according to
Uganda national guidelines and performed by officers from Kabale District and the Ministry
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of Agriculture, Animal Industries and Fisheries. The CDC National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID) Human Subjects office classified this project as non-
research because the survey was a follow-up to the confirmed outbreak in Kabale district and
the results of the study would assist the local health officials to target public health actions and
interventions based on the serosurvey results (NCEZID: 032316TS).
Study site and population
Kabale district is located in the southwestern corner of Uganda. According to the 2014 Uganda
census, it has an estimated population of 534,160 people, with the majority living in a rural set-
ting (457,592 of 534,160; 86%) [27]. The altitude of Kabale ranges from 1,219 m to 2,347 m
above sea level. Agriculture is an important source of revenue in this region. Most families
own goats, sheep, cattle, and pigs. In addition to agricultural lands, Kabale district also has
areas with high-altitude rain forests and savannahs.
Site selection strategy
From April 1–12, 2016, 34 locations in and near Kabale district were selected for inclusion in
the serosurvey by a multidisciplinary team consisting of individuals from Kabale district,
Uganda MoH, Uganda MAIF, UVRI, and CDC (Fig 1).
Four categories of people and animals were targeted for sampling based on perceived risk
of RVFV infection. These were: 1) Animal slaughter house (abattoir) workers and the animals
(cattle, goats, and sheep) slaughtered at the abattoir; 2) persons and animals from villages that
had confirmed or probable human RVF cases; 3) persons and animals from villages considered
at-risk for RVF due to geographic conditions (see below); and 4) persons and animals from
randomly selected villages with no reported RVF cases. Additionally, animals were sampled
from neighboring districts of Ntungamo and Kisoro. Since several studies have demonstrated
increased risk of RVFV exposure in butchers, we selected this as a high-risk group for sam-
pling. The research team worked with Kabale district health and veterinary officials to select
the study sites determined to be at risk for RVF; these sites were identified based on the terrain,
propensity for flooding, human and animal population density, cooperation from the commu-
nity, and sharing of international borders.
Human participant recruitment strategy
When the team arrived at a selected location, local health workers assisted in recruiting par-
ticipants for the serosurvey from the village by word of mouth. The questionnaire was writ-
ten in English but was translated to the local language (Rukiga) and administered orally by
local health workers (S1). Convenience sampling was used; all participants who presented
to the sampling site were considered eligible for the study. All participation was voluntary
and participants did not receive any compensation. Participants completed a consent form
for the questionnaire, which was translated from English into local languages and explained
by team members. Children older than 7 years were allowed to participate if a parent pro-
vided written consent. Blood samples were collected from all but 2 eligible participants
identified.
Animal sampling
Goats, sheep, and cattle that were brought to the collection site were sampled in relative pro-
portion to the size of the herd at a given study site. Due to limited grazing areas in the Kabale
region, few livestock owners maintain herds of more than 15 animals per species of cattle,
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sheep and goats. In cases where a livestock owner had less than 15 animals in a herd, all ani-
mals would be sampled. If an owner had more than 15 animals in a herd, only 25% of the herd
was sampled. Only 3 of the households we sampled reported to have more than 15 animals per
herd. We sampled all animals whose owners provided consent and presented their animals to
the survey team. Both animals with a history of previous abortions or reported as having symp-
toms compatible with RVF, and apparently healthy animals of varied ages and sexes were sam-
pled. Information collected about each herd included the general health of the herd, size of the
herd, and grazing patterns. Because some humans and animals traveled from other subcoun-
ties to the location where the study was being administered, we did not collect both human
and animal samples from all targeted subcounties.
Fig 1. Map of Kabale district showing locations where either humans and animals, or animals only, were sampled in proximity to locations where confirmed
acute or probable RVFV human outbreak cases were identified. This figure was created specifically for this manuscript in ArcGIS using open source data from ESRI
and DIVA-GIS for the background layers, and GPS points collected in the field for the points. (ESRI—http://opendata.arcgis.com/about, DIVA-GIS—http://www.diva-
gis.org/).
https://doi.org/10.1371/journal.pntd.0006412.g001
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Blood collection and laboratory testing
One ~4 cc blood sample was collected from each human and animal participant for serological
testing. Human specimens were tested by ELISA for anti-RVFV IgM and IgG, and animal
specimens were tested for anti-RVFV IgG only. ELISA testing of both human and animal sam-
ples was performed at UVRI as previously described [28]. Human blood specimens that were
IgM positive were subsequently tested by RT-PCR for RVFV-specific RNA targeting the L
genome segment[29]. Briefly, following heat and detergent inactivation, specimens were tested
by anti-RVFV-specific IgM and IgG ELISA using inactivated RVFV-infected Vero-E6 cell
antigens, using 4 dilutions of each specimen (1/100, 1/400, 1/1600, and 1/6400). Titers and the
cumulative sum optical densities of each dilution (SUMOD) minus the background absor-
bance of uninfected control antigen (adjusted SUMOD) were recorded. Samples were deemed
positive if both the adjusted SUMOD and titer were above pre-established conservative cutoff
values of0.45 for IgM ELISA and0.95 for IgG ELISA [28].
Statistical analyses
Questionnaire data were entered into a Microsoft Excel worksheet and analyzed using Stata 13
(StataCorp LP, College Station, TX, USA). The significance of human risk factors associated
with RVFV seropositivity was first determined using bivariate analysis based on Pearson’s χ2.
A p-value <0.05 was considered statistically significant. After completing the bivariate analy-
sis, the significance of independent variables as predictors was further assessed using multivar-
iate logistic regression. All risk factors found to be significantly associated with human RVFV
seropositivity were included in the multivariate logistic regression model. A Pearson’s χ2 good-
ness of fit test was done on the final model [30]. To determine if animal seropositivity at the
subcounty level was significantly associated with human seropositivity within that subcounty,
a multivariate logistic regression was performed adjusting for risk factors found to be signifi-
cant in the bivariate analysis.
Results
Participant demographics
A total of 655 persons participated in the serosurvey (Table 1). Participants were recruited at
the Kabale town abattoir (n = 117; 18% of participants), from villages where a recent acute
RVFV case had been identified (n = 237; 37%), and from villages with no recorded outbreaks
(n = 293; 45%). Most participants (n = 396; 60%) were aged 20–49 years and had completed
primary education (n = 360; 55%). The most common occupation listed was farmer or herds-
man (n = 335; 52%), and most individuals owned animals (60%). Contact with animals was
common, with 78% (n = 508) of participants reporting contact with animals in the past year.
Human and animal serology results
Of all persons tested, 13% (88/655) were RVFV seropositive. Three (0.5%) persons had anti-
RVFV IgM only, 78 (12%) had IgG only, and 7 (1%) had both IgM and IgG. Two individuals
positive for RVFV IgM also tested positive for RVFV RNA by RT-PCR, suggesting active infec-
tion at the time of sampling. The 3 IgM-only positive individuals (a trader, a housewife, and a
farmer) were all from the village in which one of the initial acute human RVFV cases was living
but were not related to the initial acute RVF case. No persons under 20 years of age were
RVFV seropositive, while 17% (n = 66) of individuals aged 20–49 years were seropositive
(Table 2). Of individuals 50 years and older, 11% (n = 22) were seropositive. Butchers were the
most likely to be RVFV seropositive, with 35% showing evidence of seropositivity. Other
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occupations evaluated for RVFV seropositive include farming at 10%, housewife at 8% (4/49),
teacher at 18% (2/11) and trader at 12.5% (3/24). In the bivariate analysis, older age groups
(χ2 = 14.4; p = 0.001), male sex (χ2 = 11.9; p = 0.001), occupation as a butcher (χ2 = 54.7;
p< 0.001), history of slaughtering or butchering animals (χ2 = 23; p< 0.001), and preparing
raw meat (χ2 = 13; p< 0.001) were all significiently associated with an increased risk of RVFV
seropositivity (S1 Table).
In the multivariate logistic regression, being a butcher and handling raw meat were signifi-
cantly associated with RVFV seropositivity, with an adjusted OR of 5.1 (95% CI 1.7–15.1;
p = 0.003) and 3.4 (95% CI 1.2–9.8; p = 0.024), respectively (Table 3). Age, sex, slaughtering/
butchering, and contact with animals through grazing were not significantly associated with
RVFV seropositivity in the multivariate model.
Of all animals tested, 13% (133/1051) were RVFV seropositive. Seropositivity varied by spe-
cies, sex, and age group among animals both in a bivariate analysis and the multivariate logistic
regression (S2 Table; Table 4). Cattle showed significantly higher odds of being seropositive
even after adjusting for age and sex (OR 9.1; 95% CI 4.1–20.5; p< 0.001). Adult animals and
females also had significantly higher odds of being RVFV seropositive, with OR 3.0 (95% CI
1.6–5.6; p = 0.001) and OR 2.1 (95% CI 1.0–4.3; p = 0.04), respectively.
Table 1. Human demographics.
Variable Number (%)
Gender
Male Sex N (%) 426 (66%)
Female Sex N (%) 218 (34%)








Secondary and Post-Secondary 141 (21%)
Marital Status N (%)














A total of 1,051 animals were sampled. Of these, 324 (31%) were cattle, 569 (54%) were goats, and 157 (15%) were
sheep. Most were adults (n = 620; 59%) and a local breed (n = 829; 79%).
https://doi.org/10.1371/journal.pntd.0006412.t001
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Human and animal seropositivity varied by subcounty (Figs 2 and 3), ranging 0–36% (stan-
dard deviation 11; mean 14%), whereas animal seropositivity ranged 4–28% (standard devia-
tion 7; mean 12%) (S3 Table). Human RVFV seropositivity was significantly associated with
close contact with cattle (P-value = 0.003), but shown not to be significant for contact with
small ruminants (p-value = 0.06) (S1 Table). The sub-counties with the highest seroprevalence
included the Kabale town council, where the main abattoir is located, and subcounties near
bodies of water or wetlands.
Table 2. RVF seropositivity of human participants.
Seronegative Seropositive IgM + IgG + IgM+ IgG +
Sex
Male 355 (83%) 71 (17%) 0 67 (16%) 3 (1%)
Female 203 (93%) 15 (7%) 3 (1%) 9 (4%) 4 (1%)
Age Group
Age 7–19 65 (100%) 0 0 0 0
Age 20–49 330 (83%) 66 (17%) 3 (1%) 57 (14%) 6 (2%)














Other 186 (93%) 15 (7%) 2 (1%) 10 (5%) 3 (1.5%)
Own Animals
No 236 (89%) 28 (11%) 1 (<1%) 25 (9%) 2 (1%)
Yes 330 (85%) 60 (15%) 2 (1%) 53 (14%) 5 (1%)
Contact with Animals
No 129 (88%) 18 (12%) 2 (1%) 14 (10%) 2 (1%)
Yes 438 (86%) 70 (14%) 1 (<1%) 64 (13%) 5 (1%)
 (house wife, trader, teacher, student, Carpenter, casual laborer, driver, mason and health workers)
https://doi.org/10.1371/journal.pntd.0006412.t002
Table 3. Multivariate analysis of risk factors for RVF seropositivity in humans.
Variable Seronegative Seropositive Adjusted Odds Ratio (OR) p-value 95% (CI)
Sex
Female 203 (93%) 15 (7%) Ref
Male 355 (83%) 71 (17%) 2.3 0.073 0.92–5.7
Age (as a continuous variable) 0.054
Occupation
Other 186 (93%) 15 (7%) Ref
Herdsman/Farmer 302 (90%) 33 (10%) 1.1 0.78 0.47–2.7
Butcher 75 (65%) 40 (35%) 5.1 0.003 1.7–15.1
Live Animal Contact
Grazing 319 (91%) 33 (9%) 0.84 0.62 0.41–1.7
Meat Preparation
Slaughtering/butchering 185 (78%) 53 (22%) 0.67 0.40 0.27–1.7
Handling raw meat 362 (84%) 71 (16%) 3.4 0.024 1.2–9.8
Adjusting for age as a continuous variable in addition to the variables listed in the table
https://doi.org/10.1371/journal.pntd.0006412.t003
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Human and animal serology association
The association between animal seropositivity and human seropositivity within a subcounty
was examined using multivariate logistic regression, adjusting for contact with raw meat and
occupation, because these were found to be significant risk factors in the univariate analysis.
Human seropositivity within a subcounty was found to be associated with animal seropositiv-
ity, with OR of 1.1 (95% CI 1.0–1.1; p< 0.001).
Discussion
Although RVFV had not been detected in Uganda since 1968, our study demonstrates that it
has likely been enzootic in Kabale district for some time. Overall, we found evidence of RVFV
seropositivity in 13% of humans and animals sampled. Our study also showed that butchers
and those who handled raw meat were most likely to be RVFV seropositive.
Similar risk factors for RVFV seropositivity have been reported in previous studies. In a
2015 study in Kenya, LaBeaud and colleagues found that male sex, increased age, history of
slaughtering livestock, history of malaise, and poor measured visual acuity were all factors for
increased seropositivity [8, 31]. Although we did not find an association with sex and RVFV
seropositivity after adjusting for other factors, such as occupation, we did find an association
with being a butcher (i.e., someone who cuts meat either at home or at a slaughterhouse) and
RVFV seropositivity. Previous studies also found that drinking raw milk may be associated
with RVFV seropositivity [32, 33], but we were not able to find this association, likely because
few individuals (36; 5%) reported drinking raw milk. Anecdotally, individuals reported not
drinking raw milk due to concerns about Brucellosis infection. We did not find a significant
association between age and seropositivity, but interestingly, no persons younger than 20 years
were found to have evidence of RVFV infection. This may be because only 6 individuals below
the age of 20 reported having close contact with livestock with the majority in this age group
reporting to be attending school, greatly reducing their risk of exposure to potentially infected
livestock.
Figs 2 and 3 show high seroprevalence, both in humans and animals, in 2 subcounties:
Buhara subcounty, bordering Rwanda, and Bubare subcounty, near Kabale town. Kabale town
contains the main abattoir, a likely source of RVFV infection in humans. However, Buhara
and Bubare subcounties are connected by the primary North-South highway between Kabale
Table 4. Multivariate logistic regression model for RVFV seropositivity in livestock.
Variable Seronegative Seropositive Adjusted OR 95% CI P-Value
Species
Sheep 151 (96%) 7 (4%) Ref
Goat 529 (93%) 40 (7%) 1.9 0.87–4.6 0.1
Cow 238 (73%) 86 (27%) 9.1 4.1–20.5 <0.001
Age
Infant 215 (94%) 13 (6%) Ref
Middle 188 (93%) 14 (7%) 1.0 0.47–2.3 0.92
Adult 514 (83%) 106 (17%) 3.0 1.6–5.6 0.001
Sex
Male 173 (94%) 10 (5%) Ref
Female 721 (86%) 121 (14%) 2.1 1.0–4.3 0.04
Adjusted for species, age and sex
https://doi.org/10.1371/journal.pntd.0006412.t004
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town and the Rwandan border, a transportation corridor that could have served as a possible
source of introduction of RVFV into Kabale district through livestock trade. A serosurvey of
livestock conducted in Rwanda showed overall seropositivity of 16.8%, with districts closest to
Tanzania showing the highest seropositivity and the 2 districts closest to the Ugandan border
having the lowest seropositivity [34]. In addition, evidence of previous RVFV circulation and
infection of livestock from samples collected in 2009 in goats from the Southeastern districts of
Ssembabule, Mpigi, Masaka and Mubende shows a total seroprevalence of approx. 10% [24].
Although the testing methodologies employed for these samples was different than the one
employed in our study, evidence of seropositivity in livestock may begin at earliest in 2009, or
possibly earlier, and may suggest that RVFV was introduced into this region following out-
breaks in neighboring countries and maintained through low level inter-epidemic transmis-
sion [34]. However, because there are no published reports of RVF seropositivity prior to
Fig 2. Map of Kabale district showing percent RVFV seropositivity for human samples by sub-county with less seropositivity in lighter colors and increasing
seropositivity in darker color. This figure was created specifically for this manuscript in ArcGIS using open source data from ESRI and DIVA-GIS for the background
layers, and GPS points collected in the field for the points. (ESRI—http://opendata.arcgis.com/about, DIVA-GIS—http://www.diva-gis.org/).
https://doi.org/10.1371/journal.pntd.0006412.g002
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2009, we cannot be certain there was no widespread circulation of RVFV before that time. Our
study suggests that RVFV transmission to humans in Kabale district is primarily due to expo-
sure to the blood and body fluids of infected livestock, given that butchers and those handling
raw meat were most likely to be RVFV-seropositive. Additionally, we found that human sero-
positivity was significantly associated with livestock seropositivity in each subcounty. Cattle
density has also been previously associated with RVF seropositivity in RVFV models [35]. In
our study, significantly more cattle were seropositive (27%) than goats (7%) or sheep (4%).
This difference could be due to mosquito feeding behavior, as mosquitoes tend to select large
and ornamented species [36]. Also, cattle are kept longer compared to goats and sheep hence
are available to exposure to mosquito bites increasing their chances of being seropositive, how-
ever other factors such as mosquitoes species involved could be playing a role in Kabale dis-
trict. For example, mosquitoes may have a preference for biting cattle compared to other
ruminants. Furthermore, sheep and goats are usually kept indoors, especially at night, while
Fig 3. Map of Kabale district showing percent RVFV seropositivity for animal samples by sub-county with less seropositivity in lighter colors and increasing
seropositivity in darker color. (ESRI—http://opendata.arcgis.com/about, DIVA-GIS—http://www.diva-gis.org/).
https://doi.org/10.1371/journal.pntd.0006412.g003
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cattle are rarely sheltered in Kabale district and thus exposed to nighttime-biting mosquitoes.
Mosquitoes collected after outbreak investigations were mostly animal-specific feeders rather
than human-specific (Julius Lutwama, personal communication), indicating that RVFV is pri-
marily transmitted by mosquitoes within animal and human populations, however, humans
are also infected from direct contact with infected animals. The mosquito species that were
trapped in this region during the 2016 RVF outbreak include mainly Aedes and Culex species.
Further investigations of the relative contribution of mosquitoes and livestock in RVFV trans-
mission are needed.
The high seroprevalence in livestock seen in Kabale town is likely due to the main abattoir,
where a majority of the animals in our survey were sampled. Animals, primarily from the
neighboring subcounties, but also from more distant subcounties, are brought there for sale
and slaughter. The high seroprevalence in animals can be attributed to the convergence of
these animals from throughout the district in one location. This high seroprevalence in abat-
toir animals may be related to beef production dynamics in Uganda where older animals that
are no longer of reproduction value are sold off by farmers for slaughter, hence more likely to
be seropositive as stated above. The corresponding high seroprevalence seen in the abattoir
workers can also be attributed to this, as well as daily occupational exposure to infected animal
blood and body fluids.
Comparing our results with serological studies conducted in the neighboring countries of
Kenya and Tanzania, where RVFV is endemic, provides some insight into our human serosur-
vey findings. In a study in coastal area of Kenya from 2009–2011 [37], RVFV seroprevalence in
humans was lower (1.8%) than in our study. Similarly, the seroprevalence in humans was only
5.2% in Mbeya region in Tanzania [38], compared to 13% in our study. We think this is mainly
because we collected samples after a confirmed outbreak or uptick in inter-epidemic transmis-
sion, unlike in the Kenya study. However, seroprevalence was higher in domestic ruminants in
another study in Garissa, Kenya (27.6%) [39] than in our study (13%). Generally, seropreva-
lence in both animals and humans is expected to be higher in RVFV-endemic regions of
Kenya and Tanzania than what we found in this study, but the risk factors identified were the
same–mainly, contact with livestock. In a study in nearby Rwanda, the seroprevalence in cattle
was 16.8%, slightly lower than 27% in our study [34]. However, these differences could be
attributed to various factors, including the serological testing protocol used, which may differ
in specificity and sensitivity. Additionally, our study identified local variations in RVFV sero-
prevalence, so the sampling strategy may also affect seropositivity results.
The extent of RVFV infection in Kabale district was greater than anticipated (as high as
36% in Bubare subcounty, and 28% in Buhara subcounty in animals) considering that the
acutely identified human cases were the first to be laboratory confirmed in Uganda since 1968.
The presence and percentage of RVFV-specific IgM, IgG and PCR-positive samples in persons
in Kabale district indicates emergence of RVFV in Kabale is localized and that specific geo-
graphical locations may show varying levels of transmission or exposure to recently infected
livestock. The level of IgG seropositivity indicates that RVFV has been circulating in the dis-
trict for some time and further studies are needed to identify when this introduction may have
occurred.
Our study had some limitations. Prior to initiating the survey, no reliable estimates of ani-
mal and human RVFV seropositivity existed, so we do not know how representative our sam-
ples are of the general population in Kabale district. In analyzing the correlation between
human seropositivity and animal seropositivity by subcounty, we assume that seropositive
humans were most likely to be exposed to RVFV within the subcounty of their residence, and
did not take into account possible exposure in other locations.
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Uganda has had a formal dedicated VHF surveillance program coordinated by UVRI and
the MoH since 2011. During the past several years, 11 independent VHF outbreaks have been
detected and confirmed by the UVRI VHF laboratory, including an outbreak of Marburg virus
in 2012 that was first detected from a case in Kabale district [40]. Because of the previous expe-
rience and enhanced training and awareness, surveillance for VHF cases has become a priority,
and healthcare workers were able to quickly identify the initial RVFV cases and immediately
send samples for laboratory confirmation. Enhanced VHF and RVFV surveillance and health
education must be continued given the potential for future RVFV re-emergence. Alongside
this serosurvey, a knowledge, attitude practice (KAP) study was conducted in Kabale district
and the findings of this KAP study has been used to design health education materials target-
ing different stakeholders [41]. For example, the education materials targeting farmers and
butchers emphasize reporting of any sick animals to veterinarians, washing hands after touch-
ing raw meat or milk, cooking meat and milk thoroughly, using of mosquito bed nets and
wearing of more protective clothing when working in high risk areas.
WHO recommends continued surveillance of RVFV during both outbreak and inter-epi-
demic periods [42]. Although RVFV rarely causes death in infected persons, the economic
consequences due to loss of livestock and animal abortions can be devastating in agricultural
communities [43]. Further studies are needed to fully understand the enzootic and endemic
presence of RVFV in Kabale and surrounding districts. A longitudinal study is underway in
Uganda to obtain samples from animals in Kabale district and throughout Uganda over several
years to determine the endemicity and spread of RVFV over time. This will help determine the
regions are at risk for RVFV outbreaks, so resources and surveillance efforts can be targeted to
detect emergent cases and initiate any necessary control efforts.
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